Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 4/20 | 0.39 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15759862 | 0.84 | HTT (0.47) | TDP1SMN1; SMN2L3MBTL1MEN1KMT2A | |
| SCHEMBL10978790 | 0.83 | L3MBTL1 (0.41) | TP53TDP1SMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL27377438 | 0.79 | ACHE (0.39) | SMN1; SMN2L3MBTL1ACHEHPGDLMNA | |
| SCHEMBL990183 | 0.77 | ACHE (0.36) | TP53TDP1SMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL4451596 | 0.75 | TSHR (0.41) | TDP1SMN1; SMN2L3MBTL1MEN1KMT2A | |
| SCHEMBL8952064 | 0.73 | NCEH1 (0.36) | — | |
| SCHEMBL9771530 | 0.72 | L3MBTL1 (0.50) | TP53TDP1SMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL28811047 | 0.72 | PDK2 (0.37) | TDP1L3MBTL1MEN1KMT2AHPGD | |
| SCHEMBL10427454 | 0.72 | TP53 (0.48) | TP53TDP1SMN1; SMN2L3MBTL1MEN1 | |
| SCHEMBL37754 | 0.71 | L3MBTL1 (0.53) | TP53TDP1SMN1; SMN2L3MBTL1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10479809-B2 | Method for producing alkenyl phosphorus compound | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2019-11-19 | — | — | US | disclosed |
| US-20190263847-A1 | METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2019-08-29 | — | — | US | disclosed |
| EP-3348561-A1 | METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND | Maruzen Petrochemical Co., Ltd. (JP) | 2018-07-18 | — | — | EP | disclosed |
| EP-2421875-B1 | HIGHLY SELECTIVE PROCESS FOR PRODUCING ORGANODIPHOSPHITES | INVISTA TECHNOLOGIES SARL (CH) | 2017-08-23 | — | — | EP | disclosed |
| EP-2421876-B1 | HIGHLY SELECTIVE PROCESS FOR PRODUCING ORGANODIPHOSPHITES | INVISTA Technologies S à r l (CH) | 2016-07-27 | — | — | EP | disclosed |
| US-8772549-B2 | Highly selective process for producing organodiphosphites | INVISTA North America S.à r.l. (US) | 2014-07-08 | — | — | US | disclosed |
| US-8604233-B2 | Lubricant composition, magnetic recording medium, and novel polyether compound | FUJIFILM CORPORATION (JP) | 2013-12-10 | — | — | US | disclosed |
| US-8178711-B2 | Method for the purification of triorganophosphites by treatment with a basic additive | INVISTA NORTH AMERICA S.A R.L. (US) | 2012-05-15 | — | — | US | disclosed |
| US-20100267991-A1 | HIGHLY SELECTIVE PROCESS FOR PRODUCING ORGANODIPHOSPHITES | INVISTA NORTH AMERICA S.A.R.L. (US) | 2010-10-21 | — | — | US | disclosed |
| US-20100267990-A1 | HIGHLY SELECTIVE PROCESS FOR PRODUCING ORGANODIPHOSPHITES | INVISTA NORTH AMERICA S.A R.L. (US) | 2010-10-21 | — | — | US | disclosed |
| US-7812171-B2 | Black pigment, black pigment dispersion and black resin composition comprising the same | FUJIFILM CORPORATION (JP) | 2010-10-12 | — | — | US | disclosed |
| US-20100247971-A1 | LUBRICANT COMPOSITION, MAGNETIC RECORDING MEDIUM, AND NOVEL POLYETHER COMPOUND | FUJIFILM CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100076212-A1 | METHOD FOR THE PURIFICATION OF TRIORGANOPHOSPHITES BY TREATMENT WITH A BASIC ADDITIVE | INVISTA NORTH AMERICA S.A R.L. (US) | 2010-03-25 | — | — | US | disclosed |
| US-7629484-B2 | Method for the purification of triorganophosphites by treatment with a basic additive | INVISTA NORTH AMERICA S.A.R.L. (US) | 2009-12-08 | — | — | US | disclosed |
| US-20080262237-A1 | BLACK PIGMENT, BLACK PIGMENT DISPERSION AND BLACK RESIN COMPOSITION COMPRISING THE SAME | FUJIFILM CORPORATION (JP) | 2008-10-23 | — | — | US | disclosed |
| US-20070219386-A1 | Method for the purification of triorganophosphites by treatment with a basic additive | INVISTA NORTH AMERICA S.A R.L. (US) | 2007-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219386-A1 | Method for the purification of triorganophosphites by treatment with a basic additive | HRH3, PHOSPHO1, HRH4 | TP53 3729/4885TDP1 2668/4885SMN1; SMN2 4509/4885 |
| US-20100247971-A1 | LUBRICANT COMPOSITION, MAGNETIC RECORDING MEDIUM, AND NOVEL POLYETHER COMPOUND | MUC1, NEFM, CA13 | TP53 3873/4885TDP1 2436/4885SMN1; SMN2 210/4885 |
| US-20100267990-A1 | HIGHLY SELECTIVE PROCESS FOR PRODUCING ORGANODIPHOSPHITES | AGPS, FDPS, DCPS | TP53 3175/4885TDP1 1991/4885SMN1; SMN2 3456/4885 |
| US-10479809-B2 | Method for producing alkenyl phosphorus compound | ORC3, OR10J3, ORAI3 | TP53 3347/4885TDP1 3180/4885SMN1; SMN2 4182/4885 |
| US-20100076212-A1 | METHOD FOR THE PURIFICATION OF TRIORGANOPHOSPHITES BY TREATMENT WITH A BASIC ADDITIVE | HRH3, PHOSPHO1, HRH4 | TP53 3729/4885TDP1 2668/4885SMN1; SMN2 4509/4885 |
| US-20080262237-A1 | BLACK PIGMENT, BLACK PIGMENT DISPERSION AND BLACK RESIN COMPOSITION COMPRISING THE SAME | DYNLL1, HNRNPL, AOX1 | TP53 4066/4885TDP1 453/4885SMN1; SMN2 973/4885 |
| US-20100267991-A1 | HIGHLY SELECTIVE PROCESS FOR PRODUCING ORGANODIPHOSPHITES | AGPS, FDPS, DCPS | TP53 3175/4885TDP1 1991/4885SMN1; SMN2 3456/4885 |
| US-20190263847-A1 | METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND | ORC3, OR10J3, ALK | TP53 3581/4885TDP1 3486/4885SMN1; SMN2 4237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.